Results 1 to 10 of about 4,842 (201)

Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I [PDF]

open access: yesFrontiers in Immunology, 2018
Cutaneous leukocytoclastic vasculitis arises from immune complex deposition and dysregulated complement activation in small blood vessels. There are many causes, including dysregulated host response to infection, drug reactions, and various autoimmune ...
Sira Nanthapisal   +9 more
doaj   +4 more sources

Gastroenterology Cases of Cutaneous Leukocytoclastic Vasculitis [PDF]

open access: yesCase Reports in Medicine, 2013
Rarely, leukocytoclastic vasculitis can result from ischemic colitis, inflammatory bowel disease, and cryoglobulinemia. There is no established standard for the treatment of leukocytoclastic vasculitis associated with gastroenterologic diseases.
Cumali Karatoprak   +8 more
doaj   +6 more sources

Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy [PDF]

open access: yesInfectious Disease Reports, 2012
Many cases of cutaneous vasculitis are druginduced with histology revealing leukocytoclastic vasculitis (LCV). We present a case of levofloxacin- associated LCV successfully treated with prednisone and cessation of the offending drug.
Dana Blyth   +2 more
doaj   +3 more sources

Cutaneous leukocytoclastic vasculitis following COVID‐19 vaccination

open access: yesJEADV Clinical Practice, 2023
Although vaccination against COVID‐19 has been proven generally safe, rare but potentially serious adverse reactions do occur. Cutaneous leukocytoclastic vasculitis is the vasculitis of small vessels.
Manuel Zoppi   +2 more
doaj   +2 more sources

Cutaneous leukocytoclastic vasculitis revealing multifocal tuberculosis

open access: yesInternational Journal of Mycobacteriology, 2013
Cutaneous leukocytoclastic vasculitis (CLV) is an inflammatory vascular disorder rarely reported to be associated with tuberculosis. The following report describes the case of a young man with multifocal tuberculosis revealed by CLV.
Mariame Meziane   +3 more
doaj   +3 more sources

Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis [PDF]

open access: yesJAAD Case Reports, 2021
During the COVID-19 pandemic, several vaccine platforms have been generated against this virus, including inactivated whole-virus vaccines, namely CoronaVac (Sinovac Life Sciences).1 It is used particularly in Asia, the Middle East, and South America.2 Dermatologic reactions such as erythema, swelling, and urticaria have been reported.1 Cutaneous ...
Rungrot Bencharattanaphakhi, MD   +1 more
doaj   +3 more sources

Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis

open access: yesGazeta Médica, 2018
A 66-year-old patient with metastatic renal clear cell carcinoma, developed palpable purpura during systemic treatment with different tyrosine kinase inhibitors (TKI).
Diogo Alpuim Costa   +6 more
doaj   +4 more sources

Cutaneous leukocytoclastic vasculitis associated with erlotinib

open access: yesIndian Journal of Dermatology, 2016
Takahiro Sawada   +2 more
doaj   +3 more sources

Leukocytoclastic Vasculitis Induced by Cocaine Adulterated with Levamisole

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2022
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis. In 50% of cases the aetiology is idiopathic but it can be linked to drugs, infections, autoimmune disorders and various types of cancer.
Alberto Barbotti   +3 more
doaj   +1 more source

Segmental cutaneous leukocytoclastic vasculitis associated with herpes zoster: a case report and literature review

open access: yesDermatology Reports, 2023
Varicella zoster virus (VZV) infection may cause large or medium vessel vasculitis, including granulomatous arteritis of the nervous system and central nervous system vasculitis.
Keiko Furuoka   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy